Irinotecan trials for Pancreatic Adenocarcinoma

All Irinotecan trials · All Pancreatic Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Irinotecan for Pancreatic Adenocarcinoma

• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
  NCT05365581 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 46 locations
• Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
  NCT04361708 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
  NCT07621718 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

Common questions

How many trials study Irinotecan for Pancreatic Adenocarcinoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.